NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages 4179-4184

  Eisfeld, Ann Kathrin ^a   Schwind, Sebastian ^a,b   Hoag, Kevin W ^a   Walker, Christopher J ^a   Liyanarachchi, Sandya ^a   Patel, Ravi ^a   Huang, Xiaomeng ^a   Markowitz, Joseph ^a   Duan, Wenrui ^a   Otterson, Gregory A ^a   Carson III, William E ^a   Marcucci, Guido ^a   Bloomfield, Clara D ^a   De La Chapelle, Albert ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; NEUROBLASTOMA RAT SARCOMA VIRAL ONCOGENE HOMOLOG; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CODON; EXON; HARVEY SARCOMA ONCOVIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIRSTEN SARCOMA ONCOVIRUS; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOMA VIRUS; VIRUS ONCOGENE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP PHOSPHOHYDROLASES; HUMANS; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MICE; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PROTEIN ISOFORMS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 84896517734     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1401727111     Document Type: Article

References (26)

1. Hall A, Marshall CJ, Spurr NK, Weiss RA (1983) Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature 303(5916):396-400. (Pubitemid 13094876)
2. Davis M, Malcolm S, Hall A, Marshall CJ (1983) Localisation of the human N-ras oncogene to chromosome 1cen - p21 by in situ hybridisation. EMBO J 2(12):2281-2283.
3. Sweet RW, et al. (1984) The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature 311(5983):273-275. (Pubitemid 14071147)
4. Rajalingam K, Schreck R, Rapp UR, Albert S (2007) Ras oncogenes and their downstream targets. Biochim Biophys Acta 1773(8):1177-1195. (Pubitemid 47125979)
5. Vetter IR, Wittinghofer A (2001) The guanine nucleotide-binding switch in three dimensions. Science 294(5545):1299-1304. (Pubitemid 33063089)
6. Vojtek AB, Hollenberg SM, Cooper JA (1993) Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74(1):205-214. (Pubitemid 23219891)
7. Castellano E, Downward J (2011) RAS interaction with PI3K: More than just another effector pathway. Genes Cancer 2(3):261-274.
8. Malumbres M, Barbacid M (2003) RAS oncogenes: The first 30 years. Nat Rev Cancer 3(6):459-465. (Pubitemid 37328850)
9. Bezieau S, et al. (2001) High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. Hum Mutat 18(3):212-224. (Pubitemid 32807900)
10. Herrmann C (2003) Ras-effector interactions: After one decade. Curr Opin Struct Biol 13(1):122-129. (Pubitemid 36170264)
11. McGrath JP, Capon DJ, Goeddel DV, Levinson AD (1984) Comparative biochemical properties of normal and activated human ras p21 protein. Nature 310(5979): 644-649. (Pubitemid 14054328)
12. Moodie SA, Willumsen BM, Weber MJ, Wolfman A (1993) Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260(5114):1658-1661. (Pubitemid 23247150)
13. Sjölander A, Yamamoto K, Huber BE, Lapetina EG (1991) Association of p21ras with phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 88(18):7908-7912.
14. Hall A, Brown R (1985) Human N-ras: cDNA cloning and gene structure. Nucleic Acids Res 13(14):5255-5268.
15. Mohr D, Frey S, Fischer T, Güttler T, Görlich D (2009) Characterisation of the passive permeability barrier of nuclear pore complexes. EMBO J 28(17):2541-2553.
16. Marshall CJ, Hall A, Weiss RA (1982) A transforming gene present in human sarcoma cell lines. Nature 299(5879):171-173. (Pubitemid 12056797)
17. Harvey JJ (1964) An unidentified virus which causes the rapid production of tumors in mice. Nature 204:1104-1105.
18. Kirsten WH, Mayer LA (1967) Morphologic responses to a murine erythroblastosis virus. J Natl Cancer Inst 39(2):311-335.
19. Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79(11):3637-3640. (Pubitemid 12014525)
20. Chang EH, Gonda MA, Ellis RW, Scolnick EM, Lowy DR (1982) Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci USA 79(16):4848-4852. (Pubitemid 12004130)
21. Carta C, et al. (2006) Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet 79(1):129-135. (Pubitemid 43927383)
22. Ward AF, Braun BS, Shannon KM (2012) Targeting oncogenic Ras signaling in hematologic malignancies. Blood 120(17):3397-3406.
23. Adjei AA (2001) Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 93(14):1062-1074. (Pubitemid 32717538)
24. Cox AD, Der CJ (2002) Ras family signaling: Therapeutic targeting. Cancer Biol Ther 1(6):599-606.
25. Thompson H (2013) US National Cancer Institute's new Ras project targets an old foe. Nat Med 19(8):949-950.
26. Colicelli J (2004) Human RAS superfamily proteins and related GTPases. Sci STKE 2004(250):RE13.